news

a clinic in inner mongolia was named by the national medical insurance bureau for "providing gynecological treatment to men", and the local government responded

2024-09-01

한어Русский языкEnglishFrançaisIndonesianSanskrit日本語DeutschPortuguêsΕλληνικάespañolItalianoSuomalainenLatina

who is providing gynecological treatment for male patients? on august 31, the national medical insurance administration issued a document stating that "hysteroscopy", "cervical cancer screening" and "cervical dilation" are all gynecological treatment items, but some male patients have also incurred such medical insurance expenses. some hospitals even conducted 1,674 such "weird" examinations in a year.

the notice mentioned that some of the cases were medical institutions switching projects to defraud medical insurance, while others were medical staff allowing female patients to use the qualifications of male insured persons to seek medical treatment. for example, medical staff at wang yanjun clinic in alxa league, inner mongolia autonomous region, conducted a "transvaginal color doppler ultrasound examination" on a female patient and then allowed the patient to use the medical insurance certificate of a male relative to settle the expenses.

after wang yanjun clinic in alxa league was named, the alxa league medical security bureau responded on september 1 through its official wechat account, saying that on june 21 this year, alxa league received suspicious data from the national medical insurance information platform anti-fraud intelligent monitoring system, involving 127 suspicious clues of wang yanjun clinic in alxa left banner. the alxa league medical insurance bureau acted quickly and sent an inspection team to investigate and verify. the inspectors compared and verified the suspicious data by reviewing medical records on site, extracting card settlement data, and checking settlement receipts. the 127 suspicious data reflected that "the current information of the insured person shows that the gender is male during the transvaginal color doppler ultrasound examination" was true, which was an illegal operation of the clinic, involving an amount of 16,128 yuan.

the response also stated that on june 22, the alxa left banner medical security bureau made the following decisions on the clinic in accordance with article 40 of the regulations on the supervision and administration of the use of medical security funds and article 53 of the alxa league basic medical insurance designated medical institution service agreement: first, the person in charge of the clinic was interviewed and required to make immediate corrections; second, the illegal fees of 16,128 yuan from wang yanjun's clinic were recovered, and a penalty of five times the amount was imposed; third, the medical insurance service agreement with the clinic was terminated; fourth, the clues of the case were handed over to the public security organs for further handling in accordance with the law; and fifth, the crackdown on fraud and insurance fraud was intensified.

it is worth mentioning that on september 1, the national healthcare security administration reported another batch of abnormal settlement issues involving gender.

according to the news, "magnetic resonance imaging of the prostate" and "free prostate-specific antigen assay" are all male medical treatment projects, but the national medical insurance bureau recently found in big data screening that some female patients actually incurred such medical insurance expenses. some hospitals even conducted 1,263 such "weird" examinations in a year.

what is the problem with men's health care for women? the national health insurance administration sorted out that some medical institutions randomly ordered examinations for the sake of charging fees, some medical institutions set up unreasonable packages for charging fees, some medical staff used templates for medical instructions to embezzle medical insurance funds, and some insured persons lent their medical insurance certificates to others to seek medical treatment under false names.